abstract |
Provided is the use of an interferon-sensitive, replication-competent clonal RNA virus in the manufacture of a medicament for treating a neoplasm in a mammal, wherein said virus is to be administered over a period of at least 20 minutes. Further provided are similar uses with specified dosages and specified classes of viruses. |